About Peptide Referee
Peptide Referee tracks the research peptide market so buyers can see what most vendor lists leave out: who a vendor is, what it can prove, what it charges, and what its own lab reports show.
Right now we track 205 vendors, 4,740 price listings across 82 peptides, and 38 sourced alerts: closures, raids, warning letters, lawsuits and other regulator actions. We publish all of it as open data.
Why we exist
Most "best peptide vendor" lists are run by people who earn more when you buy from a particular vendor, and many never test anything. We built the opposite: published methods, linked evidence, and no paid placements.
What we do
- Check vendors. Six public-information checks per vendor, each linked to its evidence: domain age, COAs, named labs, business identity, policies and payment protection. Methodology.
- Track prices. Daily $/mg prices from vendors' public product feeds, with the vendor's score beside every price. Price index.
- Log what goes wrong. Shutdowns, FDA warning letters, raids, lawsuits and look-alike domains, each dated and sourced. Alerts.
- Publish what's verifiable. 48 vendors publish batch-specific COAs; we list them and the labs they use. Third-party tested vendors.
- Test products (planned). Blind-buy lab testing at independent labs, with every result published. How testing works.
What we don't do
We don't sell peptides, take payment for rankings or reviews, or publish dosing, injection or "protocol" advice. We describe evidence, prices and law; we don't tell anyone to use these compounds. Our editorial policy explains how we write, source and correct pages.
Who we are
We haven't named our editor or scientific reviewer yet. When they join, they'll be listed here with their credentials, and the pages they sign will carry their names. Until then, our guides and peptide overviews say they're awaiting review and stay out of search results. The data pages (vendors, prices and alerts) are built from the public sources each of them links.
How we're funded
See how we make money. In short, money never buys a score, a rank or coverage.
Contact
General: [email protected]. Corrections: [email protected].